GlassScriptPhysician profile
Carey S Smith
NPI 1891068540
$4,048.22
in general payments reported to CMS, 2019-2025
10 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.01 · 2022: $3,642 · 2023: $18.47 · 2024: $151 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,956.36 | 2022 | |
| Titan Surgical Group, LLC | $653.50 | 2022 | |
| Acumed LLC | $203.63 | 2022-2025 | Acumed, Inframe Implant, Osteomed |
| Regeneron Healthcare Solutions, INC. | $76.63 | 2024 | Dupixent |
| Philips North America LLC | $58.17 | 2023-2024 | (6391) Nexcimer, (Br5) Peripheral Ivus |
| Endo Pharmaceuticals INC. | $35.01 | 2021 | |
| Alk-Abello, INC | $18.87 | 2024 | Odactra, Grastek, Ragwitek |
| Vertex Pharmaceuticals Incorporated | $15.48 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.41 | 2024 | |
| Bioventus LLC | $15.16 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.